These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37192440)

  • 1. Technical comment on: Ferrari S, et al. 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO).
    Suhm N
    Swiss Med Wkly; 2023 Apr; 153():40074. PubMed ID: 37192440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reply to comment by Suhm N on: Ferrari S, et al. 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO).
    Ferrari S; Meier C
    Swiss Med Wkly; 2023 Apr; 153():40075. PubMed ID: 37192441
    [No Abstract]   [Full Text] [Related]  

  • 3. 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO).
    Ferrari S; Lippuner K; Lamy O; Meier C
    Swiss Med Wkly; 2020 Sep; 150():w20352. PubMed ID: 33038260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Osteoporosis: Novel drug, new recommendations].
    Bégin MJ; Uebelhart B; Biver E; Ferrari S
    Rev Med Suisse; 2021 Jan; 17(720-1):63-67. PubMed ID: 33443834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and direct medical costs of hospitalizations due to osteoporotic fractures in Switzerland.
    Lippuner K; von Overbeck J; Perrelet R; Bosshard H; Jaeger P
    Osteoporos Int; 1997; 7(5):414-25. PubMed ID: 9425498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation.
    Feldstein A; Elmer PJ; Orwoll E; Herson M; Hillier T
    Arch Intern Med; 2003 Oct; 163(18):2165-72. PubMed ID: 14557214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing fracture risk and effects of osteoporosis drugs: bone mineral density and beyond.
    Davison KS; Kendler DL; Ammann P; Bauer DC; Dempster DW; Dian L; Hanley DA; Harris ST; McClung MR; Olszynski WP; Yuen CK
    Am J Med; 2009 Nov; 122(11):992-7. PubMed ID: 19854322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premenopausal Osteoporosis.
    Cohen A
    Endocrinol Metab Clin North Am; 2017 Mar; 46(1):117-133. PubMed ID: 28131128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to osteoporosis pharmacotherapy one year after osteoporotic fracture - a Swiss trauma center secondary prevention project.
    Morell S; Hemmeler C; Amsler F; Gross T
    Swiss Med Wkly; 2017; 147():w14451. PubMed ID: 28695555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparities in bone density measurement history and osteoporosis medication utilisation in Swiss women: results from the Swiss Health Survey 2007.
    Born R; Zwahlen M
    BMC Musculoskelet Disord; 2013 Jan; 14():10. PubMed ID: 23289751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians.
    Qaseem A; Forciea MA; McLean RM; Denberg TD; ; Barry MJ; Cooke M; Fitterman N; Harris RP; Humphrey LL; Kansagara D; McLean RM; Mir TP; Schünemann HJ
    Ann Intern Med; 2017 Jun; 166(11):818-839. PubMed ID: 28492856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of fragility fractures in Switzerland: results of a nationwide survey.
    Suhm N; Lamy O; Lippuner K;
    Swiss Med Wkly; 2008 Nov; 138(45-46):674-83. PubMed ID: 18855150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fracture risk, new treatments: how does the management of the osteoporosis of elderly change?].
    Aubry-Rozier B; Lamy O
    Rev Med Suisse; 2010 Mar; 6(240):569-70, 572-4. PubMed ID: 20408462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress in understanding the genetic susceptibility to osteoporosis.
    Zmuda JM; Cauley JA; Ferrell RE
    Genet Epidemiol; 1999; 16(4):356-67. PubMed ID: 10207717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary prevention of osteoporotic fractures: why not apply the evidence?
    Ferrari S
    Swiss Med Wkly; 2008 Nov; 138(45-46):656-7. PubMed ID: 19043812
    [No Abstract]   [Full Text] [Related]  

  • 16. Gynaecologists' awareness of bone healthcare in Switzerland.
    Stute P; Birkhäuser M; von Wolff M; Meier C
    Swiss Med Wkly; 2014 Feb; 144():w13931. PubMed ID: 24573548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinician's guide to prevention and treatment of osteoporosis.
    LeBoff MS; Greenspan SL; Insogna KL; Lewiecki EM; Saag KG; Singer AJ; Siris ES
    Osteoporos Int; 2022 Oct; 33(10):2049-2102. PubMed ID: 35478046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Postmenopausal osteoporosis: current treatment].
    Roux C
    Rev Med Interne; 2004 Dec; 25 Suppl 5():S568-72. PubMed ID: 15841949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sodium monofluorophosphate and calcium on bone density and fracture rate in osteoporosis.
    Bröll H; Peichl P; Wilfert H
    Lancet; 1990 Dec; 336(8728):1446-7. PubMed ID: 1978901
    [No Abstract]   [Full Text] [Related]  

  • 20. [Epidemiology of osteoporotic fractures in Switzerland].
    Lippuner K
    Rev Med Suisse; 2009 Jun; 5(207):1304-8. PubMed ID: 19626929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.